{"nct_id":"NCT00415636","title":"Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer","status":"COMPLETED","status_verified_date":"2018-03","start_date":"2007-01","start_date_type":null,"primary_completion_date":"2010-03","primary_completion_date_type":"ACTUAL","completion_date":"2010-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}